269 related articles for article (PubMed ID: 33908348)
1. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
2. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
[TBL] [Abstract][Full Text] [Related]
3. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
4. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
5. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.
Sjöberg E; Melssen M; Richards M; Ding Y; Chanoca C; Chen D; Nwadozi E; Pal S; Love DT; Ninchoji T; Shibuya M; Simons M; Dimberg A; Claesson-Welsh L
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651195
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability.
Thibeault S; Rautureau Y; Oubaha M; Faubert D; Wilkes BC; Delisle C; Gratton JP
Mol Cell; 2010 Aug; 39(3):468-76. PubMed ID: 20705246
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
8. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
Sidibé A; Polena H; Pernet-Gallay K; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H455-63. PubMed ID: 24858856
[TBL] [Abstract][Full Text] [Related]
9. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
10. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
11. Superoxide inhibition restores endothelium-dependent dilatation in aging arteries by enhancing impaired adherens junctions.
Chang F; Flavahan S; Flavahan NA
Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H805-H811. PubMed ID: 29351453
[TBL] [Abstract][Full Text] [Related]
12. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
13. Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis.
Yang B; Cai B; Deng P; Wu X; Guan Y; Zhang B; Cai W; Schaper J; Schaper W
PLoS One; 2015; 10(7):e0127931. PubMed ID: 26133549
[TBL] [Abstract][Full Text] [Related]
14. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
[TBL] [Abstract][Full Text] [Related]
15. HIF2α signaling inhibits adherens junctional disruption in acute lung injury.
Gong H; Rehman J; Tang H; Wary K; Mittal M; Chaturvedi P; Zhao YY; Komarova YA; Vogel SM; Malik AB
J Clin Invest; 2015 Feb; 125(2):652-64. PubMed ID: 25574837
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
17. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
[TBL] [Abstract][Full Text] [Related]
18. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
[TBL] [Abstract][Full Text] [Related]
19. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
[TBL] [Abstract][Full Text] [Related]
20. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
